• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT; PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED Back to Search Results
Model Number MF-410640
Medical Device Problem Code Device Appears to Trigger Rejection (1524)
Health Effect - Clinical Code Capsular Contracture (1761)
Date of Event 01/15/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A review of the device history record has been completed.No deviations or non-conformances noted.The event of capsular contracture is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.Reasons for reoperation: "exchange from textured to smooth implants due to the patient's concern with the product and capsular contracture, baker grade iii".
 
Event or Problem Description
Healthcare professional reported left side "exchange from textured to smooth implants due to the patient's concern with the product and capsular contracture, baker grade iii".Device has been explanted.
 
Additional Manufacturer Narrative
Device evaluation: visual analysis of the returned device identified, the device was underweight, and an observed opening.A microscopic analysis was performed which identified, a sharp edge break assessed, as unidentified tear break.Missing piece of the shell, and a sharp opening.A dimension measurement in the shell was performed which identified, the thickness within specification.Based on the device analysis, the final assessment is: a sharp break in the posterior side assessed, as unidentified (tear) opening.A sharp opening on the posterior side assessed, as an unidentified (tear) opening.And missing piece of the shell assessed, as inconclusive.
 
Event or Problem Description
Healthcare professional reported, left side "exchange from textured to smooth implants, due to the patient's concern with the product.And capsular contracture, baker grade iii".Device has been explanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT
Common Device Name
PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
MDR Report Key12345928
Report Number9617229-2021-48854
Device Sequence Number3821949
Product Code FTR
UDI-Device Identifier10888628003521
UDI-Public10888628003521
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P040046
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2015
Device Explanted Year2021
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/23/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date06/16/2020
Device Model NumberMF-410640
Device Catalogue NumberMF-410640
Device Lot Number2776703
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/06/2021
Initial Date Received by Manufacturer 07/22/2021
Supplement Date Received by Manufacturer08/25/2021
Initial Report FDA Received Date08/19/2021
Supplement Report FDA Received Date09/23/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age74 YR
-
-